| Biological Information | |
|---|---|
| Background Information: | Pathhunter® FcgRIIIa Clustering Cell Line (U2OS) is used to determine cross-linking based potency increases of agonist antibodies. This cell line ships as two vials of cryopreserved cells. |
| Target Class: | Checkpoint Receptor |
| Family: | IgSF (Immunoglobulin Fc Receptor ) |
| Target Name: | FcgRIIIa |
| Target Aliases: | Fc fragment of IgG receptor IIIa, CD16, FCG3, CD16A, FCGR3, IGFR3, IMD20, FCR-10, FCRIII, CD16-II, FCGRIII, FCRIIIA, FcGRIIIA |
| Target Species: | Human |
| Cell Background: | U2OS |
| Usage | |
| Product Type: | Stable Cell Lines |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store in vapor phase of liquid nitrogen. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Assay Information | |
| Assay Type: | Functional |
| Assay Measures: | Clustering |
| Detection Method: | Chemiluminescence |
| Clinical Relevance | |
| Therapeutic Area: | Oncology/Immuno-Oncology |
| Additional Information | |
| Brand: | PathHunter® |
Pathhunter® FcgRIIIa Clustering Cell Line (U2OS)
Pathhunter® FcgRIIIa Clustering Cell Line (U2OS) is used to determine cross-linking based potency increases of agonist antibodies. This cell line ships as two vials of cryopreserved cells.
User Manuals & Protocols
70-394-PathHunter-Checkpoint-Signaling-Assay-IgSF_REV3-1 User Manual
View DocumentDatasheets
93-1184C3 Datasheet
View Document